Literature DB >> 16953801

Yersinia enterocolitica YopP inhibits MAP kinase-mediated antigen uptake in dendritic cells.

Stella E Autenrieth1, Irena Soldanova, Roman Rösemann, Daniela Gunst, Naima Zahir, Michael Kracht, Klaus Ruckdeschel, Hermann Wagner, Stefan Borgmann, Ingo B Autenrieth.   

Abstract

Yersinia enterocolitica (Ye) targets mouse dendritic cells (DCs) and inhibits their ability to trigger T cell activation. Here we have investigated whether Ye might interfere with antigen presentation in DCs. Infection of DCs with the Ye wild-type strain reduced OVA uptake by DCs as demonstrated by flow cytometry and confocal laser scan microscopy. In contrast, DCs infected with Yersinia outer protein P (YopP)-deficient mutant strain rapidly internalized OVA. Furthermore, transfection of DCs with YopP, but not with a cysteine protease deficient YopP-C172A mutant, reduced uptake of OVA. This finding suggests that YopP, a virulence factor of Ye, inhibits OVA uptake by DCs. By the use of MAPK inhibitors we provide evidence that YopP mediates reduction of OVA uptake by its ability to block MAPK signalling pathways in host cells. Using transferrin (Tf) as specific marker for clathrin-mediated endocytosis (CME) and lucifer yellow (LY) as specific marker for macropinocytosis (MP) we could show that YopP inhibits CME, whereas other Yops inhibit MP. In keeping with these data, activation and proliferation of OVA-specific T cells was reduced when DCs were treated with MAPK inhibitors. Together, our data demonstrate that (i) MAPK play an important role in antigen uptake by CME in DCs, and (ii) that YopP inhibits this pathway of antigen uptake in DCs, which might contribute to evasion of adaptive immunity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16953801     DOI: 10.1111/j.1462-5822.2006.00800.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  14 in total

1.  Alternative endogenous protein processing via an autophagy-dependent pathway compensates for Yersinia-mediated inhibition of endosomal major histocompatibility complex class II antigen presentation.

Authors:  Holger Rüssmann; Klaus Panthel; Brigitte Köhn; Stefan Jellbauer; Sebastian E Winter; Sara Garbom; Hans Wolf-Watz; Sigrid Hoffmann; Silke Grauling-Halama; Gernot Geginat
Journal:  Infect Immun       Date:  2010-09-27       Impact factor: 3.441

2.  Functional Impairment of Murine Dendritic Cell Subsets following Infection with Infective Larval Stage 3 of Brugia malayi.

Authors:  Aditi Sharma; Pankaj Sharma; Achchhe Lal Vishwakarma; Mrigank Srivastava
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

3.  YopJ-promoted cytotoxicity and systemic colonization are associated with high levels of murine interleukin-18, gamma interferon, and neutrophils in a live vaccine model of Yersinia pseudotuberculosis infection.

Authors:  Yue Zhang; James B Bliska
Journal:  Infect Immun       Date:  2010-03-15       Impact factor: 3.441

Review 4.  Immunomodulatory Yersinia outer proteins (Yops)-useful tools for bacteria and humans alike.

Authors:  Benjamin Grabowski; M Alexander Schmidt; Christian Rüter
Journal:  Virulence       Date:  2017-03-15       Impact factor: 5.882

5.  Variable antigen uptake due to different expression of the macrophage mannose receptor by dendritic cells in various inbred mouse strains.

Authors:  Stella Eugenie Autenrieth; Ingo Birger Autenrieth
Journal:  Immunology       Date:  2008-10-30       Impact factor: 7.397

6.  Staphylococcus aureus phenol-soluble modulin peptides modulate dendritic cell functions and increase in vitro priming of regulatory T cells.

Authors:  Jens Schreiner; Dorothee Kretschmer; Juliane Klenk; Michael Otto; Hans-Jörg Bühring; Stefan Stevanovic; Ji Ming Wang; Sandra Beer-Hammer; Andreas Peschel; Stella E Autenrieth
Journal:  J Immunol       Date:  2013-03-04       Impact factor: 5.422

7.  Immune evasion by Yersinia enterocolitica: differential targeting of dendritic cell subpopulations in vivo.

Authors:  Stella E Autenrieth; Tanja-Rebecca Linzer; Clara Hiller; Birgit Keller; Philipp Warnke; Martin Köberle; Erwin Bohn; Tilo Biedermann; Hans-Jörg Bühring; Günter J Hämmerling; Hans-Georg Rammensee; Ingo B Autenrieth
Journal:  PLoS Pathog       Date:  2010-11-24       Impact factor: 6.823

8.  Yersinia enterocolitica targets cells of the innate and adaptive immune system by injection of Yops in a mouse infection model.

Authors:  Martin Köberle; Annegret Klein-Günther; Monika Schütz; Michaela Fritz; Susanne Berchtold; Eva Tolosa; Ingo B Autenrieth; Erwin Bohn
Journal:  PLoS Pathog       Date:  2009-08-14       Impact factor: 6.823

9.  Pathogenesis of Y. enterocolitica and Y. pseudotuberculosis in Human Yersiniosis.

Authors:  Cristi L Galindo; Jason A Rosenzweig; Michelle L Kirtley; Ashok K Chopra
Journal:  J Pathog       Date:  2011-09-12

10.  Reduced secretion of YopJ by Yersinia limits in vivo cell death but enhances bacterial virulence.

Authors:  Igor E Brodsky; Ruslan Medzhitov
Journal:  PLoS Pathog       Date:  2008-05-16       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.